Portfolio Analysis

Concentration Risk: How Much of Your Portfolio Is Apple, Microsoft, NVIDIA?

A worked example for UK investors. If you hold VWRL plus VUSA plus a tech ETF, you might be 8 to 12 per cent Apple. Magnificent 7 weight in the S&P 500, single-name look-through across all wrappers, and how to reduce concentration without selling.

By Archie RobertsUpdated 11 min read

A common moment for UK self-directed investors: you check your ISA, see a global tracker and a US tracker and a Nasdaq fund, and feel comfortable that you are diversified across hundreds of companies. Then somebody asks "how much Apple do you own?" and the honest answer is "I have no idea". The exercise of working out the answer is uncomfortable. The number is usually larger than expected.

This article is a worked example for UK retail investors. It walks through the actual single-name concentration that comes from holding two or three index funds, why this is normal but worth knowing, and what you can do about it without making panicky decisions.

This is not financial advice. Past performance does not guarantee future returns. Consider speaking to an FCA-authorised financial adviser for personalised guidance.


What the Magnificent 7 actually are

The shorthand that fund managers and journalists settled on in 2023 covers seven US large-cap names: Apple, Microsoft, Alphabet (Google), Amazon, Meta (Facebook), Nvidia and Tesla. The grouping is loose — Tesla in particular trades quite differently to the other six — but the cluster has economic cohesion. They are the largest beneficiaries of the post-2010 platform economy, the dominant US technology and consumer-internet businesses, and together they have driven a meaningful share of global equity returns since 2013.

In early 2026, the seven together represent roughly 30 per cent of the S&P 500 by weight, having peaked around 33 per cent in late 2024. Their combined market capitalisation is in the region of fifteen trillion US dollars — larger than the entire GDP of every country except the United States and China. None of this is a value judgment. It is a structural fact about cap-weighted equity indices in the current decade.

For an MSCI All Country World tracker, which is roughly 60 per cent United States, the same seven names are about 18 per cent of the global index. For a Nasdaq 100 tracker, they are around 45 to 48 per cent. For a global technology sector ETF, often more than half.


A worked example

Take a UK investor with £30,000 in a Stocks and Shares ISA, split across three holdings:

  • VWRL (Vanguard FTSE All-World UCITS ETF) — £15,000
  • VUSA (Vanguard S&P 500 UCITS ETF) — £10,000
  • EQQQ (Invesco EQQQ Nasdaq-100 UCITS ETF) — £5,000

A reasonable-looking portfolio. Three funds, global plus US plus tech satellite. Now look through.

StockWeight in VWRLWeight in VUSAWeight in EQQQ£ in VWRL£ in VUSA£ in EQQQTotal £% of portfolio
Apple4.4%7.1%9.0%£660£710£450£1,8206.1%
Microsoft3.9%6.2%8.2%£585£620£410£1,6155.4%
NVIDIA3.6%5.9%7.6%£540£590£380£1,5105.0%
Amazon2.2%3.5%5.4%£330£350£270£9503.2%
Alphabet (A+C)2.4%3.9%5.1%£360£390£255£1,0053.4%
Meta1.4%2.3%3.7%£210£230£185£6252.1%
Tesla1.0%1.6%2.9%£150£160£145£4551.5%

Magnificent 7 total: about £7,980, or 26.6 per cent of the portfolio.

Apple alone is about 6 per cent of the total, and the top three names (Apple, Microsoft, Nvidia) together are 16.5 per cent of the portfolio. This is not a portfolio of "thousands of companies" in any economically meaningful sense. It is a portfolio with three companies driving roughly one pound in six.

If the same investor adds a global technology sector ETF on top — say £5,000 in a WTEC or IUIT — the Apple weight ticks up to around 8 per cent and the Magnificent 7 total to over 30 per cent. Nothing in the brokerage interface flags this. The diversification is on the cover, not in the contents.

The numbers above are illustrative and rounded — actual fund weights drift daily and quarterly. The important point is the order of magnitude, not the decimal places. UK investors holding this kind of three- or four-fund passive portfolio routinely have eight to twelve per cent of their wealth in Apple alone, and twenty-five to thirty-five per cent in the Magnificent 7 cluster.


Why this is normal but worth knowing

Two things can be true at once: this concentration is the natural output of cap-weighted index investing, and the typical UK investor benefits from understanding the magnitude.

It is normal because:

  • Global equity markets are cap-weighted by economic logic. The biggest companies get the biggest weights, and the biggest companies right now happen to cluster in US technology.
  • The Magnificent 7 have been the strongest contributors to global equity returns over the past decade. Owning them in proportion to market cap is the default, not a deliberate bet.
  • Removing them — for example by buying an "ex-Magnificent-7" or "equal-weighted S&P" fund — is itself an active decision with its own track record and its own ongoing charges.

It is worth knowing because:

  • Decision-making improves with accurate inputs. "Eight per cent of my wealth is in Apple" is a different sentence from "I own a global tracker". Both can be true. They produce different reactions when news breaks.
  • Concentration has a non-linear effect on drawdowns. A 30 per cent fall in Apple, on an 8 per cent weight, is a 2.4 per cent hit to total portfolio value before correlated effects on Microsoft, Nvidia and the rest of the cluster.
  • Many UK investors hold the Magnificent 7 across an ISA, a SIPP and a GIA without ever consolidating the view. The total exposure is larger than any single wrapper suggests.

The honest framing is not "the Magnificent 7 are too risky" or "the Magnificent 7 will keep going up forever". It is "I should know what I own, including across wrappers I do not log into often".


How to calculate single-name concentration across all wrappers

The mechanical process for a UK investor with positions in an ISA, a SIPP and a GIA, and possibly a Lifetime ISA:

Step 1 — list every fund and direct equity in every wrapper. Pull a holdings statement from each broker. Note quantity, current value in GBP, and ticker.

Step 2 — for each fund, find the top-ten or top-twenty holdings. The issuer factsheet or KID gives this. For most ETFs the top ten are 25 to 50 per cent of the fund, so capturing the top ten gets you most of the look-through.

Step 3 — for each top-ten holding in each fund, calculate the GBP exposure. Holding weight × fund value = GBP in that company via that fund.

Step 4 — sum across funds and across wrappers. Total exposure to Apple = (£ in Apple via VWRL in ISA) + (£ in Apple via VUSA in ISA) + (£ in Apple via VWRL in SIPP) + (any direct Apple shares in GIA) + ...

Step 5 — divide by total portfolio value. That is your concentration percentage.

For a portfolio of three to five ETFs in one wrapper this takes thirty minutes in a spreadsheet. For a portfolio across three wrappers and ten or more funds, the time cost is real and the result needs updating quarterly because fund constituents change.

This is the single biggest gap in most UK retail tooling. Sharesight tracks the funds correctly but does not look through to constituents. Broker dashboards almost never look through. Spreadsheets work but require maintenance. Tools built specifically for this — Invormed is one — automate the look-through and the cross-wrapper roll-up so the answer to "how much Apple do I own" is one click rather than two evenings of spreadsheet work.


How to reduce concentration without selling

If the number turns out higher than you are comfortable with, a few options exist that do not require liquidating positions and crystallising gains.

Stop the bleed at the margin. New contributions go into something less concentrated rather than more of the same. An equal-weighted index fund, a value tilt, an ex-US ETF, or direct gilt or bond exposure all dilute single-name weight without selling. Time and contributions do the work.

Add a counter-balancing tilt. A position in an equal-weighted S&P 500 fund (EWRP, EWSP) or a global value fund mechanically reduces single-name concentration in the next-fund-bought, even if existing holdings are untouched.

Redirect dividend reinvestment. If your DRIP setting is reinvesting into the same fund, redirect to a less concentrated alternative. Same effect as the contribution argument, applied to income.

Use the GIA CGT allowance. If concentration in a GIA is genuinely uncomfortable, the £3,000 (in 2026) annual CGT allowance lets you trim without realising taxable gain. A £3,000 gain trimmed each year takes a long time on a large position, but it does compound and is tax-efficient.

Wrapper migration. If you have an over-concentrated GIA position, the "Bed and ISA" pattern (sell in GIA, repurchase inside ISA the same day) can be a tax-aware way to restructure — assuming you have ISA allowance available. Speak to an FCA-authorised adviser before executing this if you are not sure how the matching rules apply to your situation.

The common thread: concentration usually accumulates passively, and it can be unwound passively too. Forced selling on a strong week of news makes more headlines than money.


Is concentration the same as overlap?

Closely related, but not identical.

Overlap is when two funds hold the same companies — the duplication problem. Holding VWRL and VUSA produces overlap because the US large-caps in VUSA are also in VWRL. Overlap matters because you may be paying double fees and not getting the diversification you think you are.

Concentration is the resulting single-name exposure expressed as a percentage of total portfolio. Apple at 8 per cent of your portfolio is concentration; the fact that it appears in three different funds you hold is overlap. Overlap is one of the things that produces concentration; it is not the only one. Holding one S&P 500 fund still concentrates you in Apple — without any overlap — because that one fund itself has Apple at 7 per cent.

The cleanest mental model: overlap is a fund-level question, concentration is a portfolio-level question. Both matter; the second matters more for risk.


FAQ

How do I check if I own too much Apple?

The fast answer: pull the top-ten holdings of each fund you own from the issuer factsheet, multiply each Apple weight by the fund value, sum across funds and wrappers, divide by total portfolio. The slow answer: a portfolio tool that does the look-through automatically. There is no universal threshold for "too much" — but knowing the number lets you make the decision rather than wonder.

What is the Magnificent 7?

A market-coined shorthand for seven US large-cap technology and consumer-internet companies: Apple, Microsoft, Alphabet (Google), Amazon, Meta, Nvidia and Tesla. Together they represent roughly 30 per cent of the S&P 500 and around 18 per cent of an MSCI All Country World index in early 2026.

Should I worry about index concentration?

Worry is the wrong frame. Awareness is the right one. Cap-weighted indices concentrate in whichever companies are largest at any given time. That is the design, not a bug. The useful thing is to know your single-name exposure — including across all your wrappers — so when you read about a tech selloff or a Tesla news cycle, you have a real number to react to rather than a vague sense of "I'm probably fine".

How much overlap is in VWRL?

VWRL is the FTSE All-World index — roughly 4,000 companies. By itself it has no overlap because every company is held once. Overlap arises when you combine VWRL with another fund that shares constituents. VWRL plus VUSA double-counts every S&P 500 name. VWRL plus EQQQ triple-counts the largest Nasdaq names. The percentage of overlap depends on the second fund's footprint inside the first.

How do I reduce concentration without selling?

Direct new contributions and DRIP reinvestments into less concentrated funds. Add a counter-balancing tilt (equal-weighted index, value, ex-US). Use the annual CGT allowance to trim positions in a GIA gradually. Restructure GIA holdings into ISA via Bed-and-ISA where allowance permits and matching rules allow. Time and contributions do most of the work without forced disposals.

Is concentration the same as overlap?

No. Overlap is when two funds hold the same companies (a fund-level question). Concentration is the resulting single-name exposure expressed as a percentage of the total portfolio (a portfolio-level question). Overlap can produce concentration, but a single fund can also concentrate you — an S&P 500 tracker has no overlap and still gives you 7 per cent Apple.


Want this kind of analysis on your real portfolio? Invormed is in early access — join the early-access waitlist and we will let you in as we open up.

concentration-riskmagnificent-sevenetf-overlapuk-investors

See inside your ETFs — join the Invormed waitlist

Aggregate your ISA, SIPP, and GIA. Look through every ETF. Understand what you actually own. Early access — we're inviting users in batches.

Join the waitlist